Study Summary
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Interested in this trial?
Submit an InquiryInterventions
BAFFR-CAR T cellsBIOLOGICAL
First-in-human trial examining the safety and preliminary efficacy of BAFFR-CAR T cells in participants with r/r B-ALL
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| City of Hope Medical Center | Duarte | California | United States |